Annual CFI:
$136.49M+$247.74M(+222.70%)Summary
- As of today, BMRN annual cash from investing is $136.49 million, with the most recent change of +$247.74 million (+222.70%) on December 31, 2024.
- During the last 3 years, BMRN annual cash from investing has risen by +$502.80 million (+137.26%).
- BMRN annual cash from investing is now -48.37% below its all-time high of $264.35 million, reached on December 31, 2018.
Performance
BMRN Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly CFI:
-$12.59M+$15.65M(+55.41%)Summary
- As of today, BMRN quarterly cash from investing is -$12.59 million, with the most recent change of +$15.65 million (+55.41%) on June 30, 2025.
- Over the past year, BMRN quarterly cash from investing has dropped by -$103.07 million (-113.92%).
- BMRN quarterly cash from investing is now -102.73% below its all-time high of $461.25 million, reached on December 31, 2014.
Performance
BMRN Quarterly Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFI:
$19.42M-$103.07M(-84.15%)Summary
- As of today, BMRN TTM cash from investing is $19.42 million, with the most recent change of -$103.07 million (-84.15%) on June 30, 2025.
- Over the past year, BMRN TTM cash from investing has increased by +$53.94 million (+156.25%).
- BMRN TTM cash from investing is now -95.91% below its all-time high of $474.86 million, reached on September 30, 2018.
Performance
BMRN TTM Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash From Investing Formula
CFI = Cash Inflows from Investments − Cash Outflows for Investments
BMRN Cash From Investing Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1Y1 Year | +222.7% | -113.9% | +156.3% |
3Y3 Years | +137.3% | +57.6% | +116.6% |
5Y5 Years | +539.9% | +94.9% | +117.1% |
BMRN Cash From Investing Highs & Lows
PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
---|---|---|---|---|---|---|---|
3Y | 3-Year | at high | +137.3% | -113.9% | +80.6% | -85.8% | +114.1% |
5Y | 5-Year | at high | +137.3% | -111.8% | +89.5% | -85.8% | +105.3% |
All-Time | All-Time | -48.4% | +111.6% | -102.7% | +98.3% | -95.9% | +101.7% |
BMRN Cash From Investing History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Jun 2025 | - | -$12.59M(+55.4%) | $19.42M(-84.1%) |
Mar 2025 | - | -$28.24M(-137.0%) | $122.49M(-10.3%) |
Dec 2024 | $136.49M(+222.7%) | $76.40M(+572.9%) | $136.49M(+2899.2%) |
Sep 2024 | - | -$16.16M(-117.9%) | -$4.88M(+85.9%) |
Jun 2024 | - | $90.48M(+735.6%) | -$34.52M(+63.8%) |
Mar 2024 | - | -$14.24M(+78.1%) | -$95.47M(+14.2%) |
Dec 2023 | -$111.24M(-455.4%) | -$64.96M(-41.8%) | -$111.24M(-10.2%) |
Sep 2023 | - | -$45.80M(-255.1%) | -$100.99M(-28.5%) |
Jun 2023 | - | $29.53M(+198.4%) | -$78.59M(+43.0%) |
Mar 2023 | - | -$30.01M(+45.1%) | -$137.82M(-588.1%) |
Dec 2022 | -$20.03M(+94.5%) | -$54.71M(-133.8%) | -$20.03M(+3.4%) |
Sep 2022 | - | -$23.40M(+21.2%) | -$20.74M(+82.3%) |
Jun 2022 | - | -$29.70M(-133.8%) | -$117.19M(+43.6%) |
Mar 2022 | - | $87.78M(+258.4%) | -$207.74M(+43.3%) |
Dec 2021 | -$366.31M(-583.2%) | -$55.42M(+53.8%) | -$366.31M(-22.2%) |
Sep 2021 | - | -$119.85M(+0.3%) | -$299.87M(-309.0%) |
Jun 2021 | - | -$120.26M(-69.9%) | -$73.32M(+63.7%) |
Mar 2021 | - | -$70.79M(-742.0%) | -$201.81M(-276.4%) |
Dec 2020 | -$53.62M(-72.8%) | $11.03M(-89.7%) | -$53.62M(+52.8%) |
Sep 2020 | - | $106.70M(+142.9%) | -$113.54M(+33.8%) |
Jun 2020 | - | -$248.75M(-421.4%) | -$171.56M(-277.1%) |
Mar 2020 | - | $77.40M(+258.3%) | $96.86M(+412.2%) |
Dec 2019 | -$31.03M(-111.7%) | -$48.90M(-200.4%) | -$31.03M(+41.6%) |
Sep 2019 | - | $48.68M(+147.5%) | -$53.09M(-117.7%) |
Jun 2019 | - | $19.67M(+139.0%) | $300.56M(+5.2%) |
Mar 2019 | - | -$50.48M(+28.9%) | $285.61M(+8.0%) |
Dec 2018 | $264.35M(+186.5%) | -$70.96M(-117.6%) | $264.35M(-44.3%) |
Sep 2018 | - | $402.33M(+8420.2%) | $474.86M(+232.8%) |
Jun 2018 | - | $4.72M(+106.6%) | -$357.69M(+11.1%) |
Mar 2018 | - | -$71.73M(-151.4%) | -$402.24M(-31.7%) |
Dec 2017 | -$305.46M(+36.9%) | $139.55M(+132.4%) | -$305.46M(+59.5%) |
Sep 2017 | - | -$430.23M(-980.4%) | -$754.65M(-15.9%) |
Jun 2017 | - | -$39.82M(-259.0%) | -$651.36M(-21.5%) |
Mar 2017 | - | $25.05M(+108.1%) | -$536.00M(-10.7%) |
Dec 2016 | -$484.05M(+59.0%) | -$309.65M(+5.3%) | -$484.05M(-410.3%) |
Sep 2016 | - | -$326.94M(-532.8%) | -$94.85M(-156.1%) |
Jun 2016 | - | $75.54M(-1.9%) | $169.01M(+148.1%) |
Mar 2016 | - | $77.00M(-3.2%) | -$351.73M(+70.2%) |
Dec 2015 | -$1.18B(-706.3%) | $79.55M(+226.1%) | -$1.18B(-47.8%) |
Sep 2015 | - | -$63.08M(+85.8%) | -$797.90M(+13.5%) |
Jun 2015 | - | -$445.20M(+40.7%) | -$922.05M(-78.3%) |
Mar 2015 | - | -$750.87M(-262.8%) | -$517.22M(-365.8%) |
Dec 2014 | $194.56M(+165.1%) | $461.25M(+346.4%) | $194.56M(+133.9%) |
Sep 2014 | - | -$187.23M(-363.8%) | -$573.11M(-49.8%) |
Jun 2014 | - | -$40.37M(-3.3%) | -$382.57M(-16.0%) |
Mar 2014 | - | -$39.09M(+87.2%) | -$329.94M(-10.4%) |
Dec 2013 | -$298.78M(-52.7%) | -$306.42M(-9348.9%) | -$298.78M(-568.1%) |
Sep 2013 | - | $3.31M(-73.0%) | -$44.72M(+35.2%) |
Jun 2013 | - | $12.26M(+254.4%) | -$68.98M(+70.5%) |
Mar 2013 | - | -$7.94M(+84.8%) | -$233.62M(-19.4%) |
Dec 2012 | -$195.65M(-118.5%) | -$52.35M(-149.9%) | -$195.65M(-9.8%) |
Sep 2012 | - | -$20.95M(+86.3%) | -$178.21M(+17.3%) |
Jun 2012 | - | -$152.38M(-607.3%) | -$215.58M(-245.0%) |
Mar 2012 | - | $30.04M(+186.0%) | -$62.49M(+30.2%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Dec 2011 | -$89.56M(+11.6%) | -$34.91M(+40.1%) | -$89.56M(-31.2%) |
Sep 2011 | - | -$58.32M(-8360.8%) | -$68.26M(-389.6%) |
Jun 2011 | - | $706.00K(-76.2%) | -$13.94M(+49.8%) |
Mar 2011 | - | $2.97M(+121.8%) | -$27.77M(+72.6%) |
Dec 2010 | -$101.34M(-27.2%) | -$13.61M(-239.8%) | -$101.34M(+23.9%) |
Sep 2010 | - | -$4.00M(+69.5%) | -$133.25M(+22.6%) |
Jun 2010 | - | -$13.13M(+81.4%) | -$172.12M(-40.4%) |
Mar 2010 | - | -$70.60M(-55.1%) | -$122.58M(-53.9%) |
Dec 2009 | -$79.67M(-317.6%) | -$45.52M(-6.2%) | -$79.67M(+10.3%) |
Sep 2009 | - | -$42.87M(-217.8%) | -$88.85M(-184.5%) |
Jun 2009 | - | $36.40M(+231.5%) | -$31.23M(+78.9%) |
Mar 2009 | - | -$27.69M(+49.4%) | -$148.13M(-676.5%) |
Dec 2008 | -$19.08M(+87.4%) | -$54.70M(-470.8%) | -$19.08M(+42.6%) |
Sep 2008 | - | $14.75M(+118.3%) | -$33.23M(-176.3%) |
Jun 2008 | - | -$80.49M(-179.4%) | $43.56M(+155.0%) |
Mar 2008 | - | $101.36M(+247.2%) | -$79.24M(+47.5%) |
Dec 2007 | -$151.00M(+22.5%) | -$68.85M(-175.2%) | -$151.00M(+13.8%) |
Sep 2007 | - | $91.54M(+145.0%) | -$175.13M(+50.2%) |
Jun 2007 | - | -$203.29M(-786.7%) | -$351.32M(-99.6%) |
Mar 2007 | - | $29.60M(+131.8%) | -$176.00M(+9.6%) |
Dec 2006 | -$194.77M(-438.1%) | -$92.98M(-9.8%) | -$194.77M(-91.5%) |
Sep 2006 | - | -$84.65M(-202.7%) | -$101.69M(-623.6%) |
Jun 2006 | - | -$27.96M(-358.2%) | -$14.05M(-137.6%) |
Mar 2006 | - | $10.83M(>+9900.0%) | $37.37M(-35.1%) |
Dec 2005 | $57.60M(+476.7%) | $90.00K(-97.0%) | $57.60M(-12.0%) |
Sep 2005 | - | $2.99M(-87.3%) | $65.42M(-19.1%) |
Jun 2005 | - | $23.45M(-24.5%) | $80.91M(+199.0%) |
Mar 2005 | - | $31.07M(+292.7%) | $27.06M(+277.0%) |
Dec 2004 | -$15.29M(+70.0%) | $7.91M(-57.2%) | -$15.29M(+73.4%) |
Sep 2004 | - | $18.48M(+160.8%) | -$57.58M(+34.2%) |
Jun 2004 | - | -$30.40M(-169.5%) | -$87.50M(-9.9%) |
Mar 2004 | - | -$11.28M(+67.2%) | -$79.65M(-56.3%) |
Dec 2003 | -$50.95M(-171.9%) | -$34.38M(-200.3%) | -$50.95M(-399.2%) |
Sep 2003 | - | -$11.45M(+49.2%) | $17.03M(-63.2%) |
Jun 2003 | - | -$22.54M(-229.4%) | $46.31M(-37.5%) |
Mar 2003 | - | $17.42M(-48.2%) | $74.13M(+4.5%) |
Dec 2002 | $70.91M(+153.0%) | $33.60M(+88.5%) | $70.91M(+221.2%) |
Sep 2002 | - | $17.83M(+237.5%) | -$58.53M(+30.3%) |
Jun 2002 | - | $5.28M(-62.8%) | -$83.95M(+35.8%) |
Mar 2002 | - | $14.20M(+114.8%) | -$130.81M(+2.3%) |
Dec 2001 | -$133.91M(-8517.4%) | -$95.84M(-1163.0%) | -$133.91M(-281.4%) |
Sep 2001 | - | -$7.59M(+81.8%) | -$35.11M(-42.6%) |
Jun 2001 | - | -$41.59M(-474.8%) | -$24.62M(-129.0%) |
Mar 2001 | - | $11.10M(+273.6%) | -$10.75M(-591.7%) |
Dec 2000 | -$1.55M(+97.7%) | $2.97M(+2.3%) | -$1.55M(+85.3%) |
Sep 2000 | - | $2.90M(+110.5%) | -$10.61M(+83.0%) |
Jun 2000 | - | -$27.72M(-236.6%) | -$62.27M(-33.2%) |
Mar 2000 | - | $20.29M(+433.7%) | -$46.76M(+32.0%) |
Dec 1999 | -$68.75M(-739.3%) | -$6.08M(+87.5%) | -$68.75M(-9.7%) |
Sep 1999 | - | -$48.76M(-299.5%) | -$62.67M(-350.7%) |
Jun 1999 | - | -$12.20M(-617.5%) | -$13.91M(-717.5%) |
Mar 1999 | - | -$1.70M | -$1.70M |
Dec 1998 | -$8.19M(-679.2%) | - | - |
Dec 1997 | -$1.05M | - | - |
FAQ
- What is BioMarin Pharmaceutical Inc. annual cash from investing?
- What is the all-time high annual cash from investing for BioMarin Pharmaceutical Inc.?
- What is BioMarin Pharmaceutical Inc. annual cash from investing year-on-year change?
- What is BioMarin Pharmaceutical Inc. quarterly cash from investing?
- What is the all-time high quarterly cash from investing for BioMarin Pharmaceutical Inc.?
- What is BioMarin Pharmaceutical Inc. quarterly cash from investing year-on-year change?
- What is BioMarin Pharmaceutical Inc. TTM cash from investing?
- What is the all-time high TTM cash from investing for BioMarin Pharmaceutical Inc.?
- What is BioMarin Pharmaceutical Inc. TTM cash from investing year-on-year change?
What is BioMarin Pharmaceutical Inc. annual cash from investing?
The current annual cash from investing of BMRN is $136.49M
What is the all-time high annual cash from investing for BioMarin Pharmaceutical Inc.?
BioMarin Pharmaceutical Inc. all-time high annual cash from investing is $264.35M
What is BioMarin Pharmaceutical Inc. annual cash from investing year-on-year change?
Over the past year, BMRN annual cash from investing has changed by +$247.74M (+222.70%)
What is BioMarin Pharmaceutical Inc. quarterly cash from investing?
The current quarterly cash from investing of BMRN is -$12.59M
What is the all-time high quarterly cash from investing for BioMarin Pharmaceutical Inc.?
BioMarin Pharmaceutical Inc. all-time high quarterly cash from investing is $461.25M
What is BioMarin Pharmaceutical Inc. quarterly cash from investing year-on-year change?
Over the past year, BMRN quarterly cash from investing has changed by -$103.07M (-113.92%)
What is BioMarin Pharmaceutical Inc. TTM cash from investing?
The current TTM cash from investing of BMRN is $19.42M
What is the all-time high TTM cash from investing for BioMarin Pharmaceutical Inc.?
BioMarin Pharmaceutical Inc. all-time high TTM cash from investing is $474.86M
What is BioMarin Pharmaceutical Inc. TTM cash from investing year-on-year change?
Over the past year, BMRN TTM cash from investing has changed by +$53.94M (+156.25%)